Legal Representation
Attorney
Christina M. Licursi
USPTO Deadlines
Next Deadline
600 days remaining
Section 8 Declaration Due (Supplemental Register) (Based on registration date 20210817)
Due Date
August 17, 2027
Grace Period Ends
February 17, 2028
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
23 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Aug 17, 2021 | R.SR | A | REGISTERED-SUPPLEMENTAL REGISTER | Loading... |
| Jul 13, 2021 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | Loading... |
| Jul 12, 2021 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Jul 9, 2021 | CNTA | O | APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER | Loading... |
| Jun 28, 2021 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Jun 28, 2021 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jun 28, 2021 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Jun 25, 2021 | AAUA | E | NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED | Loading... |
| Jun 24, 2021 | IUAA | P | USE AMENDMENT ACCEPTED | Loading... |
| Jun 9, 2021 | AUPC | I | AMENDMENT TO USE PROCESSING COMPLETE | Loading... |
| Jun 9, 2021 | IUAF | S | USE AMENDMENT FILED | Loading... |
| Jun 8, 2021 | EAAU | I | TEAS AMENDMENT OF USE RECEIVED | Loading... |
| Mar 12, 2021 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Mar 12, 2021 | GNRT | O | NON-FINAL ACTION E-MAILED | Loading... |
| Mar 12, 2021 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Mar 10, 2021 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Mar 10, 2021 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Mar 10, 2021 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Nov 23, 2020 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Nov 23, 2020 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Nov 23, 2020 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Nov 23, 2020 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Sep 1, 2020 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
Detailed Classifications
Class 042
Medical research services; biomedical research services; structural and functional analysis of genomes; scientific research in the field of genomics; medical laboratory services being medical research, in the fields of diagnostics and development of tests for clinical diagnosis and the detection of medical conditions and disorders; providing temporary use of online, non-downloadable software for genetic assessment and identification of cancer, diseases, health status and metrics, and gene mutations for scientific, medical, diagnostic, treatment, and research purposes; providing temporary use of online, non-downloadable software used for the sequencing and analyses of genomic, proteomic, and transcriptomic data; providing temporary use of online, non-downloadable software used to integrate and create data models; software as a service (SAAS) services featuring software for analyzing and visualizing genomic, proteomic, and transcriptomic data, and evaluating health status and diagnosing diseases, disorders, and syndromes; software as a service (SAAS) services featuring software for data management, for electronic storage of data in the field of clinical trials and electronic health records; software as a service (SAAS) services featuring software for patient treatment protocols and for recommending treatments to patients; providing online, non-downloadable computer software for collecting, analyzing, reporting, and tracking data and information in the fields of genetics, genomics, proteomics, transcriptomics, and biochemistry; providing online, non-downloadable software for use in clinical trial data management and for management of electronic health records
First Use Anywhere:
20200400
First Use in Commerce:
20200400
Class 044
Genetic testing for medical purposes, specifically, genomic, proteomic, transcriptomic, and molecular medical testing for cancer and other diagnostic or treatment purposes; Providing medical information, namely, providing collected and analyzed medical information in the field of genetic and treatment information for cancer and other diseases and disorders for diagnostic and treatment purposes; Providing medical information, specifically, providing collected and analyzed medical information in the field of genomics, proteomics, transcriptomics for diagnostic and treatment purposes; providing medical data and information to healthcare professionals; providing online computer databases of genomic sequences for medical scientific research, namely, for medical tracking, matching, searching, testing, aggregating, researching, and evaluating health status, for the purpose of diagnosing diseases and gene mutations; providing an online Internet website portal featuring medical information, namely, medical, genetic, genomic, proteomic, and transcriptomic information and data in the field of cancer for diagnostic and treatment purposes; providing an online Internet website portal featuring medical information, namely, medical, genetic, genomic, proteomic, and transcriptomic information and data for scientific, laboratory, and medical research and development purposes
First Use Anywhere:
20200400
First Use in Commerce:
20200400
Additional Information
Pseudo Mark
BOSTON GENE
Classification
International Classes
042
044